Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An unusual cause of cerebral venous sinus thrombosis: prothrombin G20210A gene mutation.

Southern medical journal - 1 Sept 2007

Porres-Aguilar Mateo, Square Jaime H, Storey Raul, Rodriguez-Dunn Simon, Mohamed-Aly Mohamed S

Abstract excerpt

Cerebral venous sinus thrombosis represents less than 1% of all strokes, being an uncommon entity with a wide spectrum of clinical scenarios. We present a 45-year-old Hispanic female with a history of long-term oral contraceptive use who was diagnosed with cerebral venous sinus thrombosis due to a heterozygous carrier mutation in the prothrombin G20210A gene. The patient was successfully managed with intravenous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Anticoagulants
Share to Contraceptives, Oral, Hormonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Carrier Screening

Share to Guanine

Share to Heparin

Share to Prothrombin

Share to Thrombophilia

Source

Identifiers

PMID: 17902293
DOI: 10.1097/SMJ.0b013e3181462a5f

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An unusual cause of cerebral venous sinus thrombosis: prothrombin G20210A gene mutation.PMID 17902293Read ↗

Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebral venous thrombosis 1 month after resumption of the medication at the age of 50.Semantic proximity Read ↗

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.Semantic proximity Read ↗

[Cerebral and systemic venous thrombosis associated to prothrombin G20210 mutation: case report].Semantic proximity Read ↗

Prothrombin gene variant (G20210A) in a patient with cerebral venous sinus thrombosis.Semantic proximity Read ↗

Cerebral venous sinus thrombosis as a recurrent thrombotic event in a patient with heterozygous prothrombin G20210A genotype after discontinuation of oral anticoagulation therapy: how long should we treat these patients with warfarin?Semantic proximity Read ↗

Cerebral venous sinus thrombosis and SCN1A, a novel association?Semantic proximity Read ↗

MTHFR Gene Polymorphisms and Cardiovascular Risk Factors, Clinical-Imagistic Features and Outcome in Cerebral Venous Sinus ThrombosisSemantic proximity Read ↗

Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis.Semantic proximity Read ↗

Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.Semantic proximity Read ↗

An Exploratory Study Using Next-Generation Sequencing to Identify Prothrombotic Variants in Patients with Cerebral Vein Thrombosis.Semantic proximity Read ↗

Genetic Testing in the Diagnosis and Treatment of Cerebral venous sinus thrombosis: A Case ReportSemantic proximity Read ↗

Cerebral Thrombosis: A Neurogenetic Approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.